Fear that delayed second COVID-19 vaccine dose could lead to new variants realistic - Canada News castanet.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from castanet.net Daily Mail and Mail on Sunday newspapers.
Fear that delayed second COVID-19 vaccine dose could lead to new variants realistic
by Jacob Serebrin, The Canadian Press
Posted Feb 3, 2021 5:08 pm EDT
Last Updated Feb 3, 2021 at 5:14 pm EDT
MONTREAL Experts say delaying the second dose of some COVID-19 vaccines could lead to the emergence of new variants of the virus but there’s no sign it has happened yet.
“It’s a theoretical, realistic possibility, but there is no evidence so far,” said Dr. Andre Veillette, a professor at the Universite de Montreal and the director of the Molecular Oncology Research Unit at the Montreal Clinical Research Institute.
Veillette, who is a member of the federal government’s COVID-19 vaccine task force, said there’s a concern that the immunity provided by one dose of the Pfizer-BioNTech and Moderna vaccines “is not as strong as you would get with two doses.”
Only 0 5 Percent Moderna COVID-19 Vaccine Trial Patients Suffered Adverse Events boomlive.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boomlive.in Daily Mail and Mail on Sunday newspapers.
While the local Society scene grinded to a halt last spring due to the pandemic, it is still nice to showcase the organizations which have worked outside of the box to maintain their goals. The traditional Annual Dinner of the Montreal Clinical Research Institute (IRCM) Foundation, which took place recently, is a good example.
Reinvented in a virtual mode due to the health constraints of COVID-19, the event was a resounding success. Under the theme of Chercheuses dâespoir, highlighting IRCM women researchers, this unusual edition raised over $370,000. For the occasion, over 300 participants gathered through a high quality digital platform, where they learned more about three IRCM female researchers and their research projects, including work on COVID-19, during an encounter hosted by journalist